BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

924 related articles for article (PubMed ID: 23324398)

  • 1. A multifunctional biphasic suspension of mesoporous silica encapsulated with YVO4:Eu3+ and Fe3O4 nanoparticles: synergistic effect towards cancer therapy and imaging.
    Shanta Singh N; Kulkarni H; Pradhan L; Bahadur D
    Nanotechnology; 2013 Feb; 24(6):065101. PubMed ID: 23324398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. YVO4:Eu3+ functionalized porous silica submicrospheres as delivery carriers of doxorubicin.
    Cheng Z; Ma P; Hou Z; Wang W; Dai Y; Zhai X; Lin J
    Dalton Trans; 2012 Feb; 41(5):1481-9. PubMed ID: 22124278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Luminescent GdVO4:Eu3+ functionalized mesoporous silica nanoparticles for magnetic resonance imaging and drug delivery.
    Huang S; Cheng Z; Ma P; Kang X; Dai Y; Lin J
    Dalton Trans; 2013 May; 42(18):6523-30. PubMed ID: 23474744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A luminescent and mesoporous core-shell structured Gd2O3 : Eu(3+)@nSiO2@mSiO2 nanocomposite as a drug carrier.
    Xu Z; Gao Y; Huang S; Ma Pa; Lin J; Fang J
    Dalton Trans; 2011 May; 40(18):4846-54. PubMed ID: 21431226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two-dimensional magnetic WS2@Fe3O4 nanocomposite with mesoporous silica coating for drug delivery and imaging-guided therapy of cancer.
    Yang G; Gong H; Liu T; Sun X; Cheng L; Liu Z
    Biomaterials; 2015 Aug; 60():62-71. PubMed ID: 25985153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The properties of mesoporous silica nanoparticles functionalized with different PEG-chain length via the disulfide bond linker and drug release in glutathione medium.
    Xie Z; Gong H; Liu M; Zhu H; Sun H
    J Biomater Sci Polym Ed; 2016; 27(1):55-68. PubMed ID: 26540096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multifunctional mesoporous silica nanoparticles modified with tumor-shedable hyaluronic acid as carriers for doxorubicin.
    Zhang J; Sun Y; Tian B; Li K; Wang L; Liang Y; Han J
    Colloids Surf B Biointerfaces; 2016 Aug; 144():293-302. PubMed ID: 27107383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Facile synthesis of pH sensitive polymer-coated mesoporous silica nanoparticles and their application in drug delivery.
    Tang H; Guo J; Sun Y; Chang B; Ren Q; Yang W
    Int J Pharm; 2011 Dec; 421(2):388-96. PubMed ID: 22001840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzyme-induced and tumor-targeted drug delivery system based on multifunctional mesoporous silica nanoparticles.
    Cheng YJ; Luo GF; Zhu JY; Xu XD; Zeng X; Cheng DB; Li YM; Wu Y; Zhang XZ; Zhuo RX; He F
    ACS Appl Mater Interfaces; 2015 May; 7(17):9078-87. PubMed ID: 25893819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Covalent bridging of surface functionalized Fe3O4 and YPO4:Eu nanostructures for simultaneous imaging and therapy.
    Barick KC; Sharma A; Shetake NG; Ningthoujam RS; Vatsa RK; Babu PD; Pandey BN; Hassan PA
    Dalton Trans; 2015 Sep; 44(33):14686-96. PubMed ID: 26215789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visible-light-excited and europium-emissive nanoparticles for highly-luminescent bioimaging in vivo.
    Wu Y; Shi M; Zhao L; Feng W; Li F; Huang C
    Biomaterials; 2014 Jul; 35(22):5830-9. PubMed ID: 24746969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesoporous silica nanoparticles capped with disulfide-linked PEG gatekeepers for glutathione-mediated controlled release.
    Cui Y; Dong H; Cai X; Wang D; Li Y
    ACS Appl Mater Interfaces; 2012 Jun; 4(6):3177-83. PubMed ID: 22646097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles.
    Fan J; Fang G; Wang X; Zeng F; Xiang Y; Wu S
    Nanotechnology; 2011 Nov; 22(45):455102. PubMed ID: 22019849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TPGS functionalized mesoporous silica nanoparticles for anticancer drug delivery to overcome multidrug resistance.
    Zhao P; Li L; Zhou S; Qiu L; Qian Z; Liu X; Cao X; Zhang H
    Mater Sci Eng C Mater Biol Appl; 2018 Mar; 84():108-117. PubMed ID: 29519418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SiO2@YBO3:Eu3+ hollow mesoporous spheres for drug delivery vehicle.
    Yang G; Gai S; Qu F; Yang P
    ACS Appl Mater Interfaces; 2013 Jun; 5(12):5788-96. PubMed ID: 23705794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesoporous silica nanoparticles combining Au particles as glutathione and pH dual-sensitive nanocarriers for doxorubicin.
    Xu S; Li Y; Chen Z; Hou C; Chen T; Xu Z; Zhang X; Zhang H
    Mater Sci Eng C Mater Biol Appl; 2016 Feb; 59():258-264. PubMed ID: 26652372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic mesoporous silica nanoparticles for potential delivery of chemotherapeutic drugs and hyperthermia.
    Tao C; Zhu Y
    Dalton Trans; 2014 Nov; 43(41):15482-90. PubMed ID: 25190592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pH-responsive mesoporous silica nanoparticles-based multi-drug delivery system for overcoming multi-drug resistance.
    He Q; Gao Y; Zhang L; Zhang Z; Gao F; Ji X; Li Y; Shi J
    Biomaterials; 2011 Oct; 32(30):7711-20. PubMed ID: 21816467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and identification of multifunctional mesoporous silica nanoparticles for in vitro and in vivo dual-mode imaging, theranostics, and targeted tracking.
    Chan MH; Lin HM
    Biomaterials; 2015 Apr; 46():149-58. PubMed ID: 25678124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polyaspartic acid-anchored mesoporous silica nanoparticles for pH-responsive doxorubicin release.
    Hakeem A; Zahid F; Zhan G; Yi P; Yang H; Gan L; Yang X
    Int J Nanomedicine; 2018; 13():1029-1040. PubMed ID: 29497295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.